No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Lectin Receptors Expressed on Myeloid Cells

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
  • XML
    281.95 Kb
  • HTML
    275.96 Kb
  • PDF
    4.09 MB
  • Authors: Gordon D. Brown1, Paul R. Crocker2
  • Editor: Siamon Gordon3
    Affiliations: 1: MRC Centre for Medical Mycology, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, United Kingdom; 2: Division of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; 3: Oxford University, Oxford, United Kingdom
  • Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016
  • Received 20 May 2016 Accepted 01 August 2016 Published 23 September 2016
  • Gordon D. Brown, [email protected]; Paul R. Crocker, [email protected]
image of Lectin Receptors Expressed on Myeloid Cells
    Preview this microbiology spectrum article:
    Zoom in

    Lectin Receptors Expressed on Myeloid Cells, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/4/5/MCHD-0036-2016-1.gif /docserver/preview/fulltext/microbiolspec/4/5/MCHD-0036-2016-2.gif
  • Abstract:

    Lectins recognize a diverse array of carbohydrate structures and perform numerous essential biological functions. Here we focus on only two families of lectins, the Siglecs and C-type lectins. Triggering of intracellular signaling cascades following ligand recognition by these receptors can have profound effects on the induction and modulation of immunity. In this chapter, we provide a brief overview of each family and then focus on selected examples that highlight how these lectins can influence myeloid cell functioning in health and disease. Receptors that are discussed include Sn (Siglec-1), CD33 (Siglec-3), and Siglec-5, -7, -8, -9, -10, -11, -14, -15, -E, -F, and -G as well as Dectin-1, MICL, Dectin-2, Mincle/MCL, and the macrophage mannose receptor.

  • Citation: Brown G, Crocker P. 2016. Lectin Receptors Expressed on Myeloid Cells. Microbiol Spectrum 4(5):MCHD-0036-2016. doi:10.1128/microbiolspec.MCHD-0036-2016.


1. Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar RL, Sgroi DC, Stamenkovic K, Schauer R, Schachner M, van den Berg TK, van der Merwe PA, Watt SM, Varki A. 1998. Siglecs: a family of sialic-acid binding lectins. Glycobiology 8:v. [PubMed][CrossRef]
2. Cao H, Crocker PR. 2011. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation? Immunology 132:18–26. [PubMed][CrossRef]
3. Bensing BA, Khedri Z, Deng L, Yu H, Prakobphol A, Fisher SJ, Chen X, Iverson TM, Varki A, Sullam PM. 2016. Novel aspects of sialoglycan recognition by the Siglec-like domains of streptococcal SRR glycoproteins. Glycobiology doi:10.1093/glycob/cww042. [PubMed][CrossRef]
4. Rademacher C, Bru T, McBride R, Robison E, Nycholat CM, Kremer EJ, Paulson JC. 2012. A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid protein. Glycobiology 22:1086–1091. [PubMed][CrossRef]
5. Attrill H, Imamura A, Sharma RS, Kiso M, Crocker PR, van Aalten DM. 2006. Siglec-7 undergoes a major conformational change when complexed with the α(2,8)-disialylganglioside GT1b. J Biol Chem 281:32774–32783. [PubMed][CrossRef]
6. Kuroki K, Wang J, Ose T, Yamaguchi M, Tabata S, Maita N, Nakamura S, Kajikawa M, Kogure A, Satoh T, Arase H, Maenaka K. 2014. Structural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRα. Proc Natl Acad Sci U S A 111:8877–8882. [PubMed][CrossRef]
7. Lu Q, Lu G, Qi J, Wang H, Xuan Y, Wang Q, Li Y, Zhang Y, Zheng C, Fan Z, Yan J, Gao GF. 2014. PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. Proc Natl Acad Sci U S A 111:8221–8226. [PubMed][CrossRef]
8. Soto PC, Stein LL, Hurtado-Ziola N, Hedrick SM, Varki A. 2010. Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol 184:4185–4195. [PubMed][CrossRef]
9. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol 7:255–266. [PubMed][CrossRef]
10. Macauley MS, Crocker PR, Paulson JC. 2014. Siglec-mediated regulation of immune cell function in disease. Nat Rev Immunol 14:653–666. [PubMed][CrossRef]
11. Daëron M, Jaeger S, Du Pasquier L, Vivier E. 2008. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 224:11–43. [PubMed][CrossRef]
12. Avril T, Floyd H, Lopez F, Vivier E, Crocker PR. 2004. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol 173:6841–6849. [PubMed][CrossRef]
13. Avril T, Freeman SD, Attrill H, Clarke RG, Crocker PR. 2005. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation. J Biol Chem 280:19843–19851. [PubMed][CrossRef]
14. Crocker PR, Gordon S. 1986. Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J Exp Med 164:1862–1875. [CrossRef]
15. Klaas M, Crocker PR. 2012. Sialoadhesin in recognition of self and non-self. Semin Immunopathol 34:353–364. [PubMed][CrossRef]
16. Crocker PR, Kelm S, Dubois C, Martin B, McWilliam AS, Shotton DM, Paulson JC, Gordon S. 1991. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J 10:1661–1669. [PubMed]
17. Kelm S, Brossmer R, Isecke R, Gross HJ, Strenge K, Schauer R. 1998. Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem 255:663–672. [PubMed][CrossRef]
18. Chávez-Galán L, Olleros ML, Vesin D, Garcia I. 2015. Much more than M1 and M2 macrophages, there are also CD169 + and TCR + macrophages. Front Immunol 6:263. doi:10.3389/fimmu.2015.00263. [PubMed][CrossRef]
19. Crocker PR, Gordon S. 1989. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med 169:1333–1346. [PubMed][CrossRef]
20. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. 2001. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97:288–296. [PubMed][CrossRef]
21. Steiniger B, Barth P, Herbst B, Hartnell A, Crocker PR. 1997. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92:307–316. [PubMed][CrossRef]
22. Martinez-Pomares L, Gordon S. 2012. CD169 + macrophages at the crossroads of antigen presentation. Trends Immunol 33:66–70. [PubMed][CrossRef]
23. Vanderheijden N, Delputte PL, Favoreel HW, Vandekerckhove J, Van Damme J, van Woensel PA, Nauwynck HJ. 2003. Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages. J Virol 77:8207–8215. [PubMed][CrossRef]
24. Rempel H, Calosing C, Sun B, Pulliam L. 2008. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One 3:e1967. doi:10.1371/journal.pone.0001967. [PubMed][CrossRef]
25. Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG. 2015. Lymph node macrophages restrict murine cytomegalovirus dissemination. J Virol 89:7147–7158. [PubMed][CrossRef]
26. Frederico B, Chao B, Lawler C, May JS, Stevenson PG. 2015. Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol 96:2314–2327. [PubMed][CrossRef]
27. Bernhard CA, Ried C, Kochanek S, Brocker T. 2015. CD169 + macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells. Proc Natl Acad Sci U S A 112:5461–5466. [PubMed][CrossRef]
28. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Henrickson SE, Whelan SP, Guidotti LG, von Andrian UH. 2010. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 465:1079–1083. [PubMed][CrossRef]
29. Akiyama H, Miller C, Patel HV, Hatch SC, Archer J, Ramirez NG, Gummuluru S. 2014. Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus. J Virol 88:8813–8825. [PubMed][CrossRef]
30. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, Erikson E, Pino M, Erkizia I, Glass B, Clotet B, Keppler OT, Telenti A, Kräusslich HG, Martinez-Picado J. 2012. Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol 10:e1001448. doi:10.1371/journal.pbio.1001448. [CrossRef]
31. Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, Motamedi N, Murooka TT, Brehm MA, Greiner DL, Shultz LD, Mempel TR, Bjorkman PJ, Kumar P, Mothes W. 2015. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science 350:563–567. [PubMed][CrossRef]
32. Honke N, Shaabani N, Cadeddu G, Sorg UR, Zhang DE, Trilling M, Klingel K, Sauter M, Kandolf R, Gailus N, van Rooijen N, Burkart C, Baldus SE, Grusdat M, Löhning M, Hengel H, Pfeffer K, Tanaka M, Häussinger D, Recher M, Lang PA, Lang KS. 2011. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol 13:51–57. [PubMed][CrossRef]
33. Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, Kanagawa O, Fujii S, Tanaka M. 2011. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34:85–95. [PubMed][CrossRef]
34. Ravishankar B, Shinde R, Liu H, Chaudhary K, Bradley J, Lemos HP, Chandler P, Tanaka M, Munn DH, Mellor AL, McGaha TL. 2014. Marginal zone CD169 + macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc Natl Acad Sci U S A 111:4215–4220. [PubMed][CrossRef]
35. Backer R, Schwandt T, Greuter M, Oosting M, Jüngerkes F, Tüting T, Boon L, O’Toole T, Kraal G, Limmer A, den Haan JM. 2010. Effective collaboration between marginal metallophilic macrophages and CD8 + dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci U S A 107:216–221. [PubMed][CrossRef]
36. Veninga H, Borg EG, Vreeman K, Taylor PR, Kalay H, van Kooyk Y, Kraal G, Martinez-Pomares L, den Haan JM. 2015. Antigen targeting reveals splenic CD169 + macrophages as promoters of germinal center B-cell responses. Eur J Immunol 45:747–757. [PubMed][CrossRef]
37. Kawasaki N, Vela JL, Nycholat CM, Rademacher C, Khurana A, van Rooijen N, Crocker PR, Kronenberg M, Paulson JC. 2013. Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation. Proc Natl Acad Sci U S A 110:7826–7831. [PubMed][CrossRef]
38. Xiong YS, Cheng Y, Lin QS, Wu AL, Yu J, Li C, Sun Y, Zhong RQ, Wu LJ. 2014. Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis. Rheumatology (Oxford) 53:250–259. [PubMed][CrossRef]
39. Bao G, Han Z, Yan Z, Wang Q, Zhou Y, Yao D, Gu M, Chen B, Chen S, Deng A, Zhong R. 2010. Increased Siglec-1 expression in monocytes of patients with primary biliary cirrhosis. Immunol Invest 39:645–660. [PubMed][CrossRef]
40. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. 2007. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists. Arthritis Rheum 56:1010–1020. [PubMed][CrossRef]
41. Biesen R, Demir C, Barkhudarova F, Grün JR, Steinbrich-Zöllner M, Backhaus M, Häupl T, Rudwaleit M, Riemekasten G, Radbruch A, Hiepe F, Burmester GR, Grützkau A. 2008. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 58:1136–1145. [PubMed][CrossRef]
42. Ohnishi K, Komohara Y, Saito Y, Miyamoto Y, Watanabe M, Baba H, Takeya M. 2013. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci 104:1237–1244. [PubMed][CrossRef]
43. Ohnishi K, Yamaguchi M, Erdenebaatar C, Saito F, Tashiro H, Katabuchi H, Takeya M, Komohara Y. 2016. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma. Cancer Sci 107:846–852. [PubMed][CrossRef]
44. Ikezumi Y, Suzuki T, Hayafuji S, Okubo S, Nikolic-Paterson DJ, Kawachi H, Shimizu F, Uchiyama M. 2005. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol Dial Transplant 20:2704–2713. [PubMed][CrossRef]
45. Kidder D, Richards HE, Lyons PA, Crocker PR. 2013. Sialoadhesin deficiency does not influence the severity of lupus nephritis in New Zealand black x New Zealand white F1 mice. Arthritis Res Ther 15:R175. doi:10.1186/ar4364. [PubMed][CrossRef]
46. Groh J, Ribechini E, Stadler D, Schilling T, Lutz MB, Martini R. 2016. Sialoadhesin promotes neuroinflammation-related disease progression in two mouse models of CLN disease. Glia 64:792–809. [PubMed][CrossRef]
47. Ip CW, Kroner A, Crocker PR, Nave KA, Martini R. 2007. Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice. Neurobiol Dis 25:105–111. [PubMed][CrossRef]
48. Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R. 2006. Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. Mol Cell Neurosci 31:685–691. [PubMed][CrossRef]
49. Jiang HR, Hwenda L, Makinen K, Oetke C, Crocker PR, Forrester JV. 2006. Sialoadhesin promotes the inflammatory response in experimental autoimmune uveoretinitis. J Immunol 177:2258–2264. [PubMed][CrossRef]
50. Wu C, Rauch U, Korpos E, Song J, Loser K, Crocker PR, Sorokin LM. 2009. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol 182:6508–6516. [PubMed][CrossRef]
51. Kidder D, Richards HE, Ziltener HJ, Garden OA, Crocker PR. 2013. Sialoadhesin ligand expression identifies a subset of CD4 +Foxp3 T cells with a distinct activation and glycosylation profile. J Immunol 190:2593–2602. [PubMed][CrossRef]
52. Black LV, Saunderson SC, Coutinho FP, Muhsin-Sharafaldine MR, Damani TT, Dunn AC, McLellan AD. 2015. The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. Immunol Cell Biol 94:430–438. [PubMed][CrossRef]
53. Saunderson SC, Dunn AC, Crocker PR, McLellan AD. 2014. CD169 mediates the capture of exosomes in spleen and lymph node. Blood 123:208–216. [PubMed][CrossRef]
54. Jones C, Virji M, Crocker PR. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol Microbiol 49:1213–1225. [PubMed][CrossRef]
55. Heikema AP, Bergman MP, Richards H, Crocker PR, Gilbert M, Samsom JN, van Wamel WJ, Endtz HP, van Belkum A. 2010. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect Immun 78:3237–3246. [PubMed][CrossRef]
56. Monteiro VG, Lobato CS, Silva AR, Medina DV, de Oliveira MA, Seabra SH, de Souza W, DaMatta RA. 2005. Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages. Parasitol Res 97:380–385. [PubMed][CrossRef]
57. Klaas M, Oetke C, Lewis LE, Erwig LP, Heikema AP, Easton A, Willison HJ, Crocker PR. 2012. Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni. J Immunol 189:2414–2422. [PubMed][CrossRef]
58. Chang YC, Olson J, Louie A, Crocker PR, Varki A, Nizet V. 2014. Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus. J Mol Med (Berl) 92:951–959. [PubMed][CrossRef]
59. Erikson E, Wratil PR, Frank M, Ambiel I, Pahnke K, Pino M, Azadi P, Izquierdo-Useros N, Martinez-Picado J, Meier C, Schnaar RL, Crocker PR, Reutter W, Keppler OT. 2015. Mouse Siglec-1 mediates trans-infection of surface-bound murine leukemia virus in a sialic acid N-acyl side chain-dependent manner. J Biol Chem 290:27345–27359. [PubMed][CrossRef]
60. Akiyama H, Ramirez NG, Gudheti MV, Gummuluru S. 2015. CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies. PLoS Pathog 11:e1004751. doi:10.1371/journal.ppat.1004751. [CrossRef]
61. Puryear WB, Akiyama H, Geer SD, Ramirez NP, Yu X, Reinhard BM, Gummuluru S. 2013. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog 9:e1003291. doi:10.1371/journal.ppat.1003291. [PubMed][CrossRef]
62. Zou Z, Chastain A, Moir S, Ford J, Trandem K, Martinelli E, Cicala C, Crocker P, Arthos J, Sun PD. 2011. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One 6:e24559. doi:10.1371/journal.pone.0024559. [PubMed][CrossRef]
63. Izquierdo-Useros N, Lorizate M, McLaren PJ, Telenti A, Kräusslich HG, Martinez-Picado J. 2014. HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS Pathog 10:e1004146. doi:10.1371/journal.ppat.1004146. [PubMed][CrossRef]
64. Zheng Q, Hou J, Zhou Y, Yang Y, Xie B, Cao X. 2015. Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27. Cell Res 25:1121–1136. [PubMed][CrossRef]
65. Wu Y, Lan C, Ren D, Chen GY. 2016. Induction of Siglec-1 by endotoxin tolerance suppresses the innate immune response by promoting TGF-β1 production. J Biol Chem 291:12370–12382. [PubMed][CrossRef]
66. Taylor VC, Buckley CD, Douglas M, Cody AJ, Simmons DL, Freeman SD. 1999. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2. J Biol Chem 274:11505–11512. [PubMed][CrossRef]
67. Freeman SD, Kelm S, Barber EK, Crocker PR. 1995. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. Blood 85:2005–2012. [PubMed]
68. Walter RB, Häusermann P, Raden BW, Teckchandani AM, Kamikura DM, Bernstein ID, Cooper JA. 2008. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor. Traffic 9:267–279. [PubMed][CrossRef]
69. Walter RB, Raden BW, Kamikura DM, Cooper JA, Bernstein ID. 2005. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. Blood 105:1295–1302. [PubMed][CrossRef]
70. Walter RB, Raden BW, Zeng R, Häusermann P, Bernstein ID, Cooper JA. 2008. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2. J Leukoc Biol 83:200–211. [PubMed][CrossRef]
71. Raj T, Ryan KJ, Replogle JM, Chibnik LB, Rosenkrantz L, Tang A, Rothamel K, Stranger BE, Bennett DA, Evans DA, De Jager PL, Bradshaw EM. 2014. CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer’s disease susceptibility. Hum Mol Genet 23:2729–2736. [PubMed][CrossRef]
72. Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PL, Alzheimer Disease Neuroimaging Initiative. 2013. CD33 Alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16:848–850. [PubMed][CrossRef]
73. Griciuc A, Serrano-Pozo A, Parrado AR, Lesinski AN, Asselin CN, Mullin K, Hooli B, Choi SH, Hyman BT, Tanzi RE. 2013. Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78:631–643. [PubMed][CrossRef]
74. Tchilian EZ, Beverley PC, Young BD, Watt SM. 1994. Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen. Blood 83:3188–3198. [PubMed]
75. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107:2474–2476. [PubMed][CrossRef]
76. Angata T, Hayakawa T, Yamanaka M, Varki A, Nakamura M. 2006. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates. FASEB J 20:1964–1973. [PubMed][CrossRef]
77. Angata T, Tabuchi Y, Nakamura K, Nakamura M. 2007. Siglec-15: an immune system Siglec conserved throughout vertebrate evolution. Glycobiology 17:838–846. [PubMed][CrossRef]
78. Cao H, Lakner U, de Bono B, Traherne JA, Trowsdale J, Barrow AD. 2008. SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans. Eur J Immunol 38:2303–2315. [PubMed][CrossRef]
79. Brinkman-Van der Linden EC, Angata T, Reynolds SA, Powell LD, Hedrick SM, Varki A. 2003. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice. Mol Cell Biol 23:4199–4206. [PubMed][CrossRef]
80. Angata T, Ishii T, Motegi T, Oka R, Taylor RE, Soto PC, Chang YC, Secundino I, Gao CX, Ohtsubo K, Kitazume S, Nizet V, Varki A, Gemma A, Kida K, Taniguchi N. 2013. Loss of Siglec-14 reduces the risk of chronic obstructive pulmonary disease exacerbation. Cell Mol Life Sci 70:3199–3210. [PubMed][CrossRef]
81. Ali SR, Fong JJ, Carlin AF, Busch TD, Linden R, Angata T, Areschoug T, Parast M, Varki N, Murray J, Nizet V, Varki A. 2014. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. J Exp Med 211:1231–1242. [PubMed][CrossRef]
82. Fong JJ, Sreedhara K, Deng L, Varki NM, Angata T, Liu Q, Nizet V, Varki A. 2015. Immunomodulatory activity of extracellular Hsp70 mediated via paired receptors Siglec-5 and Siglec-14. EMBO J 34:2775–2788. [PubMed][CrossRef]
83. Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R, Moretta L, Moretta A. 1999. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med 190:793–802. [PubMed][CrossRef]
84. Nicoll G, Ni J, Liu D, Klenerman P, Munday J, Dubock S, Mattei MG, Crocker PR. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J Biol Chem 274:34089–34095. [PubMed][CrossRef]
85. Mizrahi S, Gibbs BF, Karra L, Ben-Zimra M, Levi-Schaffer F. 2014. Siglec-7 is an inhibitory receptor on human mast cells and basophils. J Allergy Clin Immunol 134:230–233. [PubMed][CrossRef]
86. Angata T, Varki A. 2000. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J Biol Chem 275:22127–22135. [PubMed][CrossRef]
87. Zhang JQ, Nicoll G, Jones C, Crocker PR. 2000. Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J Biol Chem 275:22121–22126. [PubMed][CrossRef]
88. Yamaji T, Teranishi T, Alphey MS, Crocker PR, Hashimoto Y. 2002. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to α2,8-disialyl and branched α2,6-sialyl residues: a comparison with Siglec-9. J Biol Chem 277:6324–6332. [PubMed][CrossRef]
89. Campanero-Rhodes MA, Childs RA, Kiso M, Komba S, Le Narvor C, Warren J, Otto D, Crocker PR, Feizi T. 2006. Carbohydrate microarrays reveal sulphation as a modulator of siglec binding. Biochem Biophys Res Commun 344:1141–1146. [PubMed][CrossRef]
90. Secundino I, Lizcano A, Roupé KM, Wang X, Cole JN, Olson J, Ali SR, Dahesh S, Amayreh LK, Henningham A, Varki A, Nizet V. 2016. Host and pathogen hyaluronan signal through human Siglec-9 to suppress neutrophil activation. J Mol Med (Berl) 94:219–233. [PubMed][CrossRef]
91. Redelinghuys P, Antonopoulos A, Liu Y, Campanero-Rhodes MA, McKenzie E, Haslam SM, Dell A, Feizi T, Crocker PR. 2011. Early murine T-lymphocyte activation is accompanied by a switch from N-glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E. J Biol Chem 286:34522–34532. [PubMed][CrossRef]
92. McMillan SJ, Sharma RS, McKenzie EJ, Richards HE, Zhang J, Prescott A, Crocker PR. 2013. Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling. Blood 121:2084–2094. [PubMed][CrossRef]
93. McMillan SJ, Sharma RS, Richards HE, Hegde V, Crocker PR. 2014. Siglec-E promotes β2-integrin-dependent NADPH oxidase activation to suppress neutrophil recruitment to the lung. J Biol Chem 289:20370–20376. [PubMed][CrossRef]
94. Schwarz F, Pearce OM, Wang X, Samraj AN, Läubli H, Garcia JO, Lin H, Fu X, Garcia-Bingman A, Secrest P, Romanoski CE, Heyser C, Glass CK, Hazen SL, Varki N, Varki A, Gagneux P. 2015. Siglec receptors impact mammalian lifespan by modulating oxidative stress. eLife 4:4. doi:10.7554/eLife.06184. [CrossRef]
95. Boyd CR, Orr SJ, Spence S, Burrows JF, Elliott J, Carroll HP, Brennan K, Ní Gabhann J, Coulter WA, Jones C, Crocker PR, Johnston JA, Jefferies CA. 2009. Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol 183:7703–7709. [PubMed][CrossRef]
96. Claude J, Linnartz-Gerlach B, Kudin AP, Kunz WS, Neumann H. 2013. Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst. J Neurosci 33:18270–18276. [PubMed][CrossRef]
97. Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, van de Vlekkert D, D’Azzo A, Zheng P, Liu Y. 2014. Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. eLife 3:e04066. doi:10.7554/eLife.04066. [CrossRef]
98. Läubli H, Pearce OM, Schwarz F, Siddiqui SS, Deng L, Stanczak MA, Deng L, Verhagen A, Secrest P, Lusk C, Schwartz AG, Varki NM, Bui JD, Varki A. 2014. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci U S A 111:14211–14216. [PubMed][CrossRef]
99. Perdicchio M, Ilarregui JM, Verstege MI, Cornelissen LA, Schetters ST, Engels S, Ambrosini M, Kalay H, Veninga H, den Haan JM, van Berkel LA, Samsom JN, Crocker PR, Sparwasser T, Berod L, Garcia-Vallejo JJ, van Kooyk Y, Unger WW. 2016. Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells. Proc Natl Acad Sci U S A 113:3329–3334. [PubMed][CrossRef]
100. Spence S, Greene MK, Fay F, Hams E, Saunders SP, Hamid U, Fitzgerald M, Beck J, Bains BK, Smyth P, Themistou E, Small DM, Schmid D, O’Kane CM, Fitzgerald DC, Abdelghany SM, Johnston JA, Fallon PG, Burrows JF, McAuley DF, Kissenpfennig A, Scott CJ. 2015.Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. Sci Transl Med 7:303ra140. doi:10.1126/scitranslmed.aab3459. [CrossRef]
101. Hudak JE, Canham SM, Bertozzi CR. 2014. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat Chem Biol 10:69–75. [PubMed][CrossRef]
102. Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Démoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Münz C, von Gunten S. 2014. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest 124:1810–1820. [PubMed][CrossRef]
103. Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR. 2003. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur J Immunol 33:1642–1648. [PubMed][CrossRef]
104. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113:3333–3336. [PubMed][CrossRef]
105. Chang YC, Olson J, Beasley FC, Tung C, Zhang J, Crocker PR, Varki A, Nizet V. 2014. Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo. PLoS Pathog 10:e1003846. doi:10.1371/journal.ppat.1003846.
106. Floyd H, Ni J, Cornish AL, Zeng Z, Liu D, Carter KC, Steel J, Crocker PR. 2000. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem 275:861–866. [PubMed][CrossRef]
107. Kikly KK, Bochner BS, Freeman SD, Tan KB, Gallagher KT, D’alessio KJ, Holmes SD, Abrahamson JA, Erickson-Miller CL, Murdock PR, Tachimoto H, Schleimer RP, White JR. 2000. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol 105:1093–1100. [PubMed][CrossRef]
108. Bochner BS, Alvarez RA, Mehta P, Bovin NV, Blixt O, White JR, Schnaar RL. 2005. Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem 280:4307–4312. [PubMed][CrossRef]
109. Jia Y, Yu H, Fernandes SM, Wei Y, Gonzalez-Gil A, Motari MG, Vajn K, Stevens WW, Peters AT, Bochner BS, Kern RC, Schleimer RP, Schnaar RL. 2015. Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells. J Allergy Clin Immunol 135:799–810.e7. doi:10.1016/j.jaci.2015.01.004. [PubMed][CrossRef]
110. Patnode ML, Cheng CW, Chou CC, Singer MS, Elin MS, Uchimura K, Crocker PR, Khoo KH, Rosen SD. 2013. Galactose 6- O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue. J Biol Chem 288:26533–26545. [PubMed][CrossRef]
111. Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, Macglashan DW, Jr, Bochner BS. 2008. Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. J Allergy Clin Immunol 121:499–505. [PubMed][CrossRef]
112. Hudson SA, Bovin NV, Schnaar RL, Crocker PR, Bochner BS. 2009. Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6′-sulfated sialyl Lewis X. J Pharmacol Exp Ther 330:608–612. [PubMed][CrossRef]
113. Nutku E, Aizawa H, Hudson SA, Bochner BS. 2003. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 101:5014–5020. [PubMed][CrossRef]
114. Gao PS, Shimizu K, Grant AV, Rafaels N, Zhou LF, Hudson SA, Konno S, Zimmermann N, Araujo MI, Ponte EV, Cruz AA, Nishimura M, Su SN, Hizawa N, Beaty TH, Mathias RA, Rothenberg ME, Barnes KC, Bochner BS. 2010. Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma. Eur J Hum Genet 18:713–719. [PubMed][CrossRef]
115. Angata T, Hingorani R, Varki NM, Varki A. 2001. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem 276:45128–45136. [PubMed][CrossRef]
116. Tateno H, Crocker PR, Paulson JC. 2005. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6′-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology 15:1125–1135. [PubMed][CrossRef]
117. Zhang JQ, Biedermann B, Nitschke L, Crocker PR. 2004. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur J Immunol 34:1175–1184. [PubMed][CrossRef]
118. Mao H, Kano G, Hudson SA, Brummet M, Zimmermann N, Zhu Z, Bochner BS. 2013. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen. PLoS One 8:e68143. doi:10.1371/journal.pone.0068143. [CrossRef]
119. McMillan SJ, Richards HE, Crocker PR. 2014. Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model. Immunol Lett 160:11–16. [PubMed][CrossRef]
120. Zhang M, Angata T, Cho JY, Miller M, Broide DH, Varki A. 2007. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109:4280–4287. [PubMed][CrossRef]
121. Li N, Zhang W, Wan T, Zhang J, Chen T, Yu Y, Wang J, Cao X. 2001. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. J Biol Chem 276:28106–28112. [PubMed][CrossRef]
122. Munday J, Kerr S, Ni J, Cornish AL, Zhang JQ, Nicoll G, Floyd H, Mattei MG, Moore P, Liu D, Crocker PR. 2001. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem J 355:489–497. [PubMed][CrossRef]
123. Whitney G, Wang S, Chang H, Cheng KY, Lu P, Zhou XD, Yang WP, McKinnon M, Longphre M. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem 268:6083–6096. [PubMed][CrossRef]
124. Zhang P, Lu X, Tao K, Shi L, Li W, Wang G, Wu K. 2015. Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. J Surg Res 194:107–113. [PubMed][CrossRef]
125. Duong BH, Tian H, Ota T, Completo G, Han S, Vela JL, Ota M, Kubitz M, Bovin N, Paulson JC, Nemazee D. 2010. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med 207:173–187. [PubMed][CrossRef]
126. Escalona Z, Álvarez B, Uenishi H, Toki D, Yuste M, Revilla C, del Moral MG, Alonso F, Ezquerra A, Domínguez J. 2015. Molecular characterization of porcine Siglec-10 and analysis of its expression in blood and tissues. Dev Comp Immunol 48:116–123. [PubMed][CrossRef]
127. Hutzler S, Özgör L, Naito-Matsui Y, Kläsener K, Winkler TH, Reth M, Nitschke L. 2014. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells. J Immunol 192:5406–5414. [PubMed][CrossRef]
128. Pfrengle F, Macauley MS, Kawasaki N, Paulson JC. 2013. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J Immunol 191:1724–1731. [PubMed][CrossRef]
129. Hoffmann A, Kerr S, Jellusova J, Zhang J, Weisel F, Wellmann U, Winkler TH, Kneitz B, Crocker PR, Nitschke L. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol 8:695–704. [PubMed][CrossRef]
130. Chen GY, Tang J, Zheng P, Liu Y. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323:1722–1725. [PubMed][CrossRef]
131. Chen GY, Brown NK, Zheng P, Liu Y. 2014. Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity. Glycobiology 24:800–806. [PubMed][CrossRef]
132. Stephenson HN, Mills DC, Jones H, Milioris E, Copland A, Dorrell N, Wren BW, Crocker PR, Escors D, Bajaj-Elliott M. 2014. Pseudaminic acid on Campylobacter jejuni flagella modulates dendritic cell IL-10 expression via Siglec-10 receptor: a novel flagellin-host interaction. J Infect Dis 210:1487–1498. [PubMed][CrossRef]
133. Angata T, Kerr SC, Greaves DR, Varki NM, Crocker PR, Varki A. 2002. Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia. J Biol Chem 277:24466–24474. [PubMed][CrossRef]
134. Wang Y, Neumann H. 2010. Alleviation of neurotoxicity by microglial human Siglec-11. J Neurosci 30:3482–3488. [PubMed][CrossRef]
135. Shahraz A, Kopatz J, Mathy R, Kappler J, Winter D, Kapoor S, Schütza V, Scheper T, Gieselmann V, Neumann H. 2015. Anti-inflammatory activity of low molecular weight polysialic acid on human macrophages. Sci Rep 5:16800. doi:10.1038/srep16800. [PubMed][CrossRef]
136. Wang X, Mitra N, Cruz P, Deng L, NISC Comparative Sequencing Program, Varki N, Angata T, Green ED, Mullikin J, Hayakawa T, Varki A, Varki A. 2012. Evolution of Siglec-11 and Siglec-16 genes in hominins. Mol Biol Evol 29:2073–2086. [PubMed][CrossRef]
137. Takamiya R, Ohtsubo K, Takamatsu S, Taniguchi N, Angata T. 2013. The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway. Glycobiology 23:178–187. [PubMed][CrossRef]
138. Hiruma Y, Hirai T, Tsuda E. 2011. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation. Biochem Biophys Res Commun 409:424–429. [PubMed][CrossRef]
139. Ishida-Kitagawa N, Tanaka K, Bao X, Kimura T, Miura T, Kitaoka Y, Hayashi K, Sato M, Maruoka M, Ogawa T, Miyoshi J, Takeya T. 2012. Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12). J Biol Chem 287:17493–17502. [PubMed][CrossRef]
140. Hiruma Y, Tsuda E, Maeda N, Okada A, Kabasawa N, Miyamoto M, Hattori H, Fukuda C. 2013. Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice. Bone 53:87–93. [PubMed][CrossRef]
141. Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, Angata T, Kinjo M, Minami A, Iwasaki N. 2013. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. J Bone Miner Res 28:2463–2475. [PubMed][CrossRef]
142. Stuible M, Moraitis A, Fortin A, Saragosa S, Kalbakji A, Filion M, Tremblay GB. 2014. Mechanism and function of monoclonal antibodies targeting Siglec-15 for therapeutic inhibition of osteoclastic bone resorption. J Biol Chem 289:6498–6512. [PubMed][CrossRef]
143. Zelensky AN, Gready JE. 2005. The C-type lectin-like domain superfamily. FEBS J 272:6179–6217. [PubMed][CrossRef]
144. McEver RP. 2015. Selectins: initiators of leucocyte adhesion and signalling at the vascular wall. Cardiovasc Res 107:331–339. [PubMed][CrossRef]
145. Willment JA, Brown GD. 2008. C-type lectin receptors in antifungal immunity. Trends Microbiol 16:27–32. [PubMed][CrossRef]
146. Sancho D, Reis e Sousa C. 2012. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 30:491–529. [PubMed][CrossRef]
147. Geijtenbeek TB, Gringhuis SI. 2009. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 9:465–479. [PubMed][CrossRef]
148. Garcia-Vallejo JJ, van Kooyk Y. 2013. The physiological role of DC-SIGN: a tale of mice and men. Trends Immunol 34:482–486. [PubMed][CrossRef]
149. Willment JA, Gordon S, Brown GD. 2001. Characterization of the human β-glucan receptor and its alternatively spliced isoforms. J Biol Chem 276:43818–43823. [PubMed][CrossRef]
150. Kato Y, Adachi Y, Ohno N. 2006. Contribution of N-linked oligosaccharides to the expression and functions of β-glucan receptor, Dectin-1. Biol Pharm Bull 29:1580–1586. [PubMed][CrossRef]
151. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, Brown GD. 2005. The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 35:1539–1547. [PubMed][CrossRef]
152. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. 2009. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321–330. [PubMed][CrossRef]
153. Sun WK, Lu X, Li X, Sun QY, Su X, Song Y, Sun HM, Shi Y. 2012. Dectin-1 is inducible and plays a crucial role in Aspergillus-induced innate immune responses in human bronchial epithelial cells. Eur J Clin Microbiol Infect Dis 31:2755–2764. [PubMed][CrossRef]
154. Bertuzzi M, Schrettl M, Alcazar-Fuoli L, Cairns TC, Muñoz A, Walker LA, Herbst S, Safari M, Cheverton AM, Chen D, Liu H, Saijo S, Fedorova ND, Armstrong-James D, Munro CA, Read ND, Filler SG, Espeso EA, Nierman WC, Haas H, Bignell EM. 2014. The pH-responsive PacC transcription factor of Aspergillus fumigatus governs epithelial entry and tissue invasion during pulmonary aspergillosis. PLoS Pathog 10:e1004413. doi:10.1371/journal.ppat.1004413. [CrossRef]
155. Brown GD, Gordon S. 2001. Immune recognition. A new receptor for β-glucans. Nature 413:36–37. [PubMed][CrossRef]
156. Drummond RA, Brown GD. 2011. The role of Dectin-1 in the host defence against fungal infections. Curr Opin Microbiol 14:392–399. [PubMed][CrossRef]
157. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C, Jacobs L, Jansen T, Verheijen K, Masthoff L, Morré SA, Vriend G, Williams DL, Perfect JR, Joosten LA, Wijmenga C, van der Meer JW, Adema GJ, Kullberg BJ, Brown GD, Netea MG. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767. [PubMed][CrossRef]
158. Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M, Rotter JI, Wang HL, McGovern DP, Brown GD, Underhill DM. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314–1317. [PubMed][CrossRef]
159. Sainz J, Lupiáñez CB, Segura-Catena J, Vazquez L, Ríos R, Oyonarte S, Hemminki K, Försti A, Jurado M. 2012. Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One 7:e32273. doi:10.1371/journal.pone.0032273. [CrossRef]
160. Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S, Brown GD. 2007. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat Immunol 8:31–38. [PubMed][CrossRef]
161. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, Kinjo T, Nakamura K, Kawakami K, Iwakura Y. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8:39–46. [PubMed][CrossRef]
162. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, Steele C. 2009. Requisite role for the Dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 182:4938–4946. [PubMed][CrossRef]
163. Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A, Mora-Montes HM, Kerrigan A, Netea MG, Murray GI, Maccallum DM, Wheeler R, Munro CA, Gow NA, Cramer RA, Brown AJ, Brown GD. 2013. Differential adaptation of Candida albicans in vivo modulates immune recognition by Dectin-1. PLoS Pathog 9:e1003315. doi:10.1371/journal.ppat.1003315. [CrossRef]
164. Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A. 2007. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 179:3463–3471. [PubMed][CrossRef]
165. Marakalala MJ, Guler R, Matika L, Murray G, Jacobs M, Brombacher F, Rothfuchs AG, Sher A, Brown GD. 2011. The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice. Microbes Infect 13:198–201. [PubMed][CrossRef]
166. Lefèvre L, Lugo-Villarino G, Meunier E, Valentin A, Olagnier D, Authier H, Duval C, Dardenne C, Bernad J, Lemesre JL, Auwerx J, Neyrolles O, Pipy B, Coste A. 2013. The C-type lectin receptors Dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum. Immunity 38:1038–1049. [PubMed][CrossRef]
167. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R, III, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, Takashima A. 2000. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem 275:20157–20167. [PubMed][CrossRef]
168. Thiagarajan PS, Yakubenko VP, Elsori DH, Yadav SP, Willard B, Tan CD, Rodriguez ER, Febbraio M, Cathcart MK. 2013. Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. Cardiovasc Res 99:494–504. [PubMed][CrossRef]
169. Szilagyi K, Gijbels MJ, van der Velden S, Heinsbroek SE, Kraal G, de Winther MP, van den Berg TK. 2015. Dectin-1 deficiency does not affect atherosclerosis development in mice. Atherosclerosis 239:318–321. [PubMed][CrossRef]
170. Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown GD, Tiraby G, Roblin X, Verrier B, Genin C, Corthésy B, Paul S. 2013. Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells. PLoS Biol 11:e1001658. doi:10.1371/journal.pbio.1001658. [PubMed][CrossRef]
171. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D, Blanchard V, Winkler A, Hess C, Reid DM, Majoul IV, Strait RT, Harris NL, Köhl G, Wex E, Ludwig R, Zillikens D, Nimmerjahn F, Finkelman FD, Brown GD, Ehlers M, Köhl J. 2012. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med 18:1401–1406. [PubMed][CrossRef]
172. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A. 2013. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342:447–453. [PubMed][CrossRef]
173. Seifert L, Deutsch M, Alothman S, Alqunaibit D, Werba G, Pansari M, Pergamo M, Ochi A, Torres-Hernandez A, Levie E, Tippens D, Greco SH, Tiwari S, Ly NN, Eisenthal A, van Heerden E, Avanzi A, Barilla R, Zambirinis CP, Rendon M, Daley D, Pachter HL, Hajdu C, Miller G. 2015. Dectin-1 regulates hepatic fibrosis and hepatocarcinogenesis by suppressing TLR4 signaling pathways. Cell Rep 13:1909–1921. [PubMed][CrossRef]
174. Chiba S, Ikushima H, Ueki H, Yanai H, Kimura Y, Hangai S, Nishio J, Negishi H, Tamura T, Saijo S, Iwakura Y, Taniguchi T. 2014. Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses. eLife 3:e04177. doi:10.7554/eLife.04177. [PubMed][CrossRef]
175. Deng Z, Ma S, Zhou H, Zang A, Fang Y, Li T, Shi H, Liu M, Du M, Taylor PR, Zhu HH, Chen J, Meng G, Li F, Chen C, Zhang Y, Jia XM, Lin X, Zhang X, Pearlman E, Li X, Feng GS, Xiao H. 2015. Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses. Nat Immunol 16:642–652. [PubMed][CrossRef]
176. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, Reis e Sousa C. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:507–517. [PubMed][CrossRef]
177. Drummond RA, Brown GD. 2013. Signalling C-type lectins in antimicrobial immunity. PLoS Pathog 9:e1003417. doi:10.1371/journal.ppat.1003417. [PubMed]
178. Wevers BA, Kaptein TM, Zijlstra-Willems EM, Theelen B, Boekhout T, Geijtenbeek TB, Gringhuis SI. 2014. Fungal engagement of the C-type lectin mincle suppresses dectin-1-induced antifungal immunity. Cell Host Microbe 15:494–505. [PubMed][CrossRef]
179. Jia XM, Tang B, Zhu LL, Liu YH, Zhao XQ, Gorjestani S, Hsu YM, Yang L, Guan JH, Xu GT, Lin X. 2014. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity. J Exp Med 211:2307–2321. [PubMed][CrossRef]
180. Glocker EO, Hennigs A, Nabavi M, Schäffer AA, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S, Manguiat A, Rezaei N, Amirzargar AA, Plebani A, Hannesschläger N, Gross O, Ruland J, Grimbacher B. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735. [PubMed][CrossRef]
181. Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651–656. [PubMed][CrossRef]
182. Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, Mollenkopf HJ, Hanke K, Gross O, Ruland J, Kaufmann SH. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J Exp Med 207:777–792. [PubMed][CrossRef]
183. del Fresno C, Soulat D, Roth S, Blazek K, Udalova I, Sancho D, Ruland J, Ardavín C. 2013. Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38:1176–1186. [PubMed][CrossRef]
184. Goodridge HS, Simmons RM, Underhill DM. 2007. Dectin-1 stimulation by Candida albicans yeast or zymosan triggers NFAT activation in macrophages and dendritic cells. J Immunol 178:3107–3115. [PubMed][CrossRef]
185. Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. 2010. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 207:923–931. [PubMed][CrossRef]
186. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, Geijtenbeek TB. 2009. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat Immunol 10:203–213. [PubMed][CrossRef]
187. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz V, Reis e Sousa C, Gordon S, Brown GD. 2004. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood 104:4038–4045. [PubMed][CrossRef]
188. Strijbis K, Tafesse FG, Fairn GD, Witte MD, Dougan SK, Watson N, Spooner E, Esteban A, Vyas VK, Fink GR, Grinstein S, Ploegh HL. 2013. Bruton’s tyrosine kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages. PLoS Pathog 9:e1003446. doi:10.1371/journal.ppat.1003446. [PubMed][CrossRef]
189. Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, Bose N, Chan AS, Magee AS, Danielson ME, Weiss A, Vasilakos JP, Underhill DM. 2011. Activation of the innate immune receptor Dectin-1 upon formation of a ‘phagocytic synapse.’ Nature 472:471–475. [PubMed][CrossRef]
190. Goodridge HS, Shimada T, Wolf AJ, Hsu YM, Becker CA, Lin X, Underhill DM. 2009. Differential use of CARD9 by Dectin-1 in macrophages and dendritic cells. J Immunol 182:1146–1154. [PubMed][CrossRef]
191. Ma J, Becker C, Lowell CA, Underhill DM. 2012. Dectin-1-triggered recruitment of light chain 3 protein to phagosomes facilitates major histocompatibility complex class II presentation of fungal-derived antigens. J Biol Chem 287:34149–34156. [PubMed][CrossRef]
192. Plato A, Willment JA, Brown GD. 2013. C-type lectin-like receptors of the Dectin-1 cluster: ligands and signaling pathways. Int Rev Immunol 32:134–156. [PubMed][CrossRef]
193. Branzk N, Lubojemska A, Hardison SE, Wang Q, Gutierrez MG, Brown GD, Papayannopoulos V. 2014. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat Immunol 15:1017–1025. [PubMed][CrossRef]
194. Mansour MK, Tam JM, Khan NS, Seward M, Davids PJ, Puranam S, Sokolovska A, Sykes DB, Dagher Z, Becker C, Tanne A, Reedy JL, Stuart LM, Vyas JM. 2013. Dectin-1 activation controls maturation of β-1,3-glucan-containing phagosomes. J Biol Chem 288:16043–16054. [PubMed][CrossRef]
195. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekhout T, Geijtenbeek TB. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome. Nat Immunol 13:246–254. [PubMed][CrossRef]
196. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, Ruland J. 2009. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459:433–436. [PubMed][CrossRef]
197. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5:487–497. [PubMed][CrossRef]
198. Zwolanek F, Riedelberger M, Stolz V, Jenull S, Istel F, Köprülü AD, Ellmeier W, Kuchler K. 2014. The non-receptor tyrosine kinase Tec controls assembly and activity of the noncanonical caspase-8 inflammasome. PLoS Pathog 10:e1004525. doi:10.1371/journal.ppat.1004525. [PubMed][CrossRef]
199. Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, Adema GJ, Kullberg BJ, Schweighoffer E, Tybulewicz V, Mora-Montes HM, Gow NA, Williams DL, Netea MG, Brown GD. 2008. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur J Immunol 38:500–506. [PubMed][CrossRef]
200. Dennehy KM, Willment JA, Williams DL, Brown GD. 2009. Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways. Eur J Immunol 39:1379–1386. [PubMed][CrossRef]
201. Li X, Utomo A, Cullere X, Choi MM, Milner DA, Jr, Venkatesh D, Yun SH, Mayadas TN. 2011. The β-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe 10:603–615. [PubMed][CrossRef]
202. Huang JH, Lin CY, Wu SY, Chen WY, Chu CL, Brown GD, Chuu CP, Wu-Hsieh BA. 2015. CR3 and Dectin-1 collaborate in macrophage cytokine response through association on lipid rafts and activation of Syk-JNK-AP-1 pathway. PLoS Pathog 11:e1004985. doi:10.1371/journal.ppat.1004985. [PubMed]
203. LeibundGut-Landmann S, Gross O, Robinson MJ, Osorio F, Slack EC, Tsoni SV, Schweighoffer E, Tybulewicz V, Brown GD, Ruland J, Reis e Sousa C. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8:630–638. [PubMed][CrossRef]
204. Osorio F, LeibundGut-Landmann S, Lochner M, Lahl K, Sparwasser T, Eberl G, Reis e Sousa C. 2008. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38:3274–3281. [PubMed][CrossRef]
205. Hernández-Santos N, Gaffen SL. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11:425–435. [PubMed][CrossRef]
206. Gringhuis SI, Wevers BA, Kaptein TM, van Capel TM, Theelen B, Boekhout T, de Jong EC, Geijtenbeek TB. 2011. Selective C-Rel activation via Malt1 controls anti-fungal T H-17 immunity by dectin-1 and dectin-2. PLoS Pathog 7:e1001259. doi:10.1371/journal.ppat.1001259. [PubMed][CrossRef]
207. Carter RW, Thompson C, Reid DM, Wong SY, Tough DF. 2006. Preferential induction of CD4 + T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J Immunol 177:2276–2284. [PubMed][CrossRef]
208. Leibundgut-Landmann S, Osorio F, Brown GD, Reis e Sousa C. 2008. Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses. Blood 12:4971–4980. [PubMed][CrossRef]
209. Rieber N, Singh A, Öz H, Carevic M, Bouzani M, Amich J, Ost M, Ye Z, Ballbach M, Schäfer I, Mezger M, Klimosch SN, Weber AN, Handgretinger R, Krappmann S, Liese J, Engeholm M, Schüle R, Salih HR, Marodi L, Speckmann C, Grimbacher B, Ruland J, Brown GD, Beilhack A, Loeffler J, Hartl D. 2015. Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells. Cell Host Microbe 17:507–514. [PubMed][CrossRef]
210. Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LA, Xavier RJ, van der Meer JW, Stunnenberg HG, Netea MG. 2012. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12:223–232. [PubMed][CrossRef]
211. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, Manjeri GR, Li Y, Ifrim DC, Arts RJ, van der Veer BM, Deen PM, Logie C, O’Neill LA, Willems P, van de Veerdonk FL, van der Meer JW, Ng A, Joosten LA, Wijmenga C, Stunnenberg HG, Xavier RJ, Netea MG. 2014. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345:1250684. doi:10.1126/science.1250684. [PubMed][CrossRef]
212. Rivera A, Hohl TM, Collins N, Leiner I, Gallegos A, Saijo S, Coward JW, Iwakura Y, Pamer EG. 2011. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med 208:369–381. [PubMed][CrossRef]
213. Kashem SW, Igyártó BZ, Gerami-Nejad M, Kumamoto Y, Mohammed J, Jarrett E, Drummond RA, Zurawski SM, Zurawski G, Berman J, Iwasaki A, Brown GD, Kaplan DH. 2015. Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation. Immunity 42:356–366. [PubMed][CrossRef]
214. Drummond RA, Dambuza IM, Vautier S, Taylor JA, Reid DM, Bain CC, Underhill DM, Masopust D, Kaplan DH, Brown GD. 2016. CD4 + T-cell survival in the GI tract requires Dectin-1 during fungal infection. Mucosal Immunol 9:492–502. [PubMed][CrossRef]
215. Tang C, Kamiya T, Liu Y, Kadoki M, Kakuta S, Oshima K, Hattori M, Takeshita K, Kanai T, Saijo S, Ohno N, Iwakura Y. 2015. Inhibition of Dectin-1 signaling ameliorates colitis by inducing Lactobacillus-mediated regulatory T cell expansion in the intestine. Cell Host Microbe 18:183–197. [PubMed][CrossRef]
216. Marshall AS, Willment JA, Lin HH, Williams DL, Gordon S, Brown GD. 2004. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 279:14792–14802. [PubMed][CrossRef]
217. Pyz E, Huysamen C, Marshall AS, Gordon S, Taylor PR, Brown GD. 2008. Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand. Eur J Immunol 38:1157–1163. [PubMed][CrossRef]
218. Marshall AS, Willment JA, Pyz E, Dennehy KM, Reid DM, Dri P, Gordon S, Wong SY, Brown GD. 2006. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation. Eur J Immunol 36:2159–2169. [PubMed][CrossRef]
219. van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G. 2007. The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells. Blood 110:2659–2666. [PubMed][CrossRef]
220. Larsen HO, Roug AS, Just T, Brown GD, Hokland P. 2012. Expression of the hMICL in acute myeloid leukemia—a highly reliable disease marker at diagnosis and during follow-up. Cytometry B Clin Cytom 82:3–8. [PubMed][CrossRef]
221. Zhao X, Singh S, Pardoux C, Zhao J, Hsi ED, Abo A, Korver W. 2010. Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia. Haematologica 95:71–78. [PubMed][CrossRef]
222. Roug AS, Larsen HO, Nederby L, Just T, Brown G, Nyvold CG, Ommen HB, Hokland P. 2014. hMICL and CD123 in combination with a CD45/CD34/CD117 backbone—a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia. Br J Haematol 164:212–222. [PubMed][CrossRef]
223. Kasahara S, Clark EA. 2012. Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α dendritic cell subset. J Leukoc Biol 91:437–448. [PubMed][CrossRef]
224. Lahoud MH, Proietto AI, Ahmet F, Kitsoulis S, Eidsmo L, Wu L, Sathe P, Pietersz S, Chang HW, Walker ID, Maraskovsky E, Braley H, Lew AM, Wright MD, Heath WR, Shortman K, Caminschi I. 2009. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J Immunol 182:7587–7594. [PubMed][CrossRef]
225. Han Y, Zhang M, Li N, Chen T, Zhang Y, Wan T, Cao X. 2004. KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity. Blood 104:2858–2866. [PubMed][CrossRef]
226. Chen CH, Floyd H, Olson NE, Magaletti D, Li C, Draves K, Clark EA. 2006. Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 107:1459–1467. [PubMed][CrossRef]
227. Begun J, Lassen KG, Jijon HB, Baxt LA, Goel G, Heath RJ, Ng A, Tam JM, Kuo SY, Villablanca EJ, Fagbami L, Oosting M, Kumar V, Schenone M, Carr SA, Joosten LA, Vyas JM, Daly MJ, Netea MG, Brown GD, Wijmenga C, Xavier RJ. 2015. Integrated genomics of Crohn’s disease risk variant identifies a role for CLEC12A in antibacterial autophagy. Cell Rep 11:1905–1918. [PubMed][CrossRef]
228. Neumann K, Castiñeiras-Vilariño M, Höckendorf U, Hannesschläger N, Lemeer S, Kupka D, Meyermann S, Lech M, Anders HJ, Kuster B, Busch DH, Gewies A, Naumann R, Groß O, Ruland J. 2014. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Immunity 40:389–399. [PubMed][CrossRef]
229. Gagné V, Marois L, Levesque JM, Galarneau H, Lahoud MH, Caminschi I, Naccache PH, Tessier P, Fernandes MJ. 2013. Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications. Arthritis Res Ther 15:R73. doi:10.1186/ar4250. [CrossRef]
230. Redelinghuys P, Whitehead L, Augello A, Drummond RA, Levesque JM, Vautier S, Reid DM, Kerscher B, Taylor JA, Nigrovic PA, Wright J, Murray GI, Willment JA, Hocking LJ, Fernandes MJ, De Bari C, McInnes IB, Brown GD. 2016. MICL controls inflammation in rheumatoid arthritis. Ann Rheum Dis 75:1386–1391. [PubMed][CrossRef]
231. Oğuz AK, Yılmaz S, Akar N, Özdağ H, Gürler A, Ateş A, Oygür CS, Kılıçoğlu SS, Demirtaş S. 2015. C-type lectin domain family 12, member A: a common denominator in Behçet’s syndrome and acute gouty arthritis. Med Hypotheses 85:186–191. [PubMed][CrossRef]
232. Kerscher B, Willment JA, Brown GD. 2013. The Dectin-2 family of C-type lectin-like receptors: an update. Int Immunol 25:271–277. [PubMed][CrossRef]
233. Sato K, Yang XL, Yudate T, Chung JS, Wu J, Luby-Phelps K, Kimberly RP, Underhill D, Cruz PD, Jr, Ariizumi K. 2006. Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor γ chain to induce innate immune responses. J Biol Chem 281:38854–38866. [PubMed][CrossRef]
234. Bi L, Gojestani S, Wu W, Hsu YM, Zhu J, Ariizumi K, Lin X. 2010. CARD9 mediates Dectin-2-induced IκBα kinase ubiquitination leading to activation of NF-κB in response to stimulation by the hyphal form of Candida albicans. J Biol Chem 285:25969–25977. [PubMed][CrossRef]
235. Robinson MJ, Osorio F, Rosas M, Freitas RP, Schweighoffer E, Gross O, Verbeek JS, Ruland J, Tybulewicz V, Brown GD, Moita LF, Taylor PR, Reis e Sousa C. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206:2037–2051. [PubMed][CrossRef]
236. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. 2010. Dectin-2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681–691. [PubMed][CrossRef]
237. Strasser D, Neumann K, Bergmann H, Marakalala MJ, Guler R, Rojowska A, Hopfner KP, Brombacher F, Urlaub H, Baier G, Brown GD, Leitges M, Ruland J. 2012. Syk kinase-coupled C-type lectin receptors engage protein kinase C-σ to elicit Card9 adaptor-mediated innate immunity. Immunity 36:32–42. [PubMed][CrossRef]
238. Gorjestani S, Yu M, Tang B, Zhang D, Wang D, Lin X. 2011. Phospholipase Cγ2 (PLCγ2) is key component in Dectin-2 signaling pathway, mediating anti-fungal innate immune responses. J Biol Chem 286:43651–43659. [PubMed][CrossRef]
239. Ariizumi K, Shen GL, Shikano S, Ritter R, III, Zukas P, Edelbaum D, Morita A, Takashima A. 2000. Cloning of a second dendritic cell-associated C-type lectin (dectin-2) and its alternatively spliced isoforms. J Biol Chem 275:11957–11963. [PubMed][CrossRef]
240. Taylor PR, Reid DM, Heinsbroek SE, Brown GD, Gordon S, Wong SY. 2005. Dectin-2 is predominantly myeloid restricted and exhibits unique activation-dependent expression on maturing inflammatory monocytes elicited in vivo. Eur J Immunol 35:2163–2174. [PubMed][CrossRef]
241. Loures FV, Röhm M, Lee CK, Santos E, Wang JP, Specht CA, Calich VL, Urban CF, Levitz SM. 2015. Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by Dectin-2 and results in formation of extracellular traps. PLoS Pathog 11:e1004643. doi:10.1371/journal.ppat.1004643. [PubMed][CrossRef]
242. McGreal EP, Rosas M, Brown GD, Zamze S, Wong SY, Gordon S, Martinez-Pomares L, Taylor PR. 2006. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology 16:422–430. [PubMed][CrossRef]
243. Yonekawa A, Saijo S, Hoshino Y, Miyake Y, Ishikawa E, Suzukawa M, Inoue H, Tanaka M, Yoneyama M, Oh-Hora M, Akashi K, Yamasaki S. 2014. Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria. Immunity 41:402–413. [PubMed][CrossRef]
244. Ifrim DC, Bain JM, Reid DM, Oosting M, Verschueren I, Gow NA, van Krieken JH, Brown GD, Kullberg BJ, Joosten LA, van der Meer JW, Koentgen F, Erwig LP, Quintin J, Netea MG. 2014. Role of Dectin-2 for host defense against systemic infection with Candida glabrata. Infect Immun 82:1064–1073. [PubMed][CrossRef]
245. Ishikawa T, Itoh F, Yoshida S, Saijo S, Matsuzawa T, Gonoi T, Saito T, Okawa Y, Shibata N, Miyamoto T, Yamasaki S. 2013. Identification of distinct ligands for the C-type lectin receptors Mincle and Dectin-2 in the pathogenic fungus Malassezia. Cell Host Microbe 13:477–488. [PubMed][CrossRef]
246. Wang H, LeBert V, Hung CY, Galles K, Saijo S, Lin X, Cole GT, Klein BS, Wüthrich M. 2014. C-type lectin receptors differentially induce Th17 cells and vaccine immunity to the endemic mycosis of North America. J Immunol 192:1107–1119. [PubMed][CrossRef]
247. Taylor PR, Roy S, Leal SM, Jr, Sun Y, Howell SJ, Cobb BA, Li X, Pearlman E. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. Nat Immunol 15:143–151. [PubMed][CrossRef]
248. Wüthrich M, Wang H, Li M, Lerksuthirat T, Hardison SE, Brown GD, Klein B. 2015. Fonsecaea pedrosoi-induced Th17-cell differentiation in mice is fostered by Dectin-2 and suppressed by Mincle recognition. Eur J Immunol 45:2542–2552. [PubMed][CrossRef]
249. Nakamura Y, Sato K, Yamamoto H, Matsumura K, Matsumoto I, Nomura T, Miyasaka T, Ishii K, Kanno E, Tachi M, Yamasaki S, Saijo S, Iwakura Y, Kawakami K. 2015. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans. Infect Immun 83:671–681. [PubMed][CrossRef]
250. Aragane Y, Maeda A, Schwarz A, Tezuka T, Ariizumi K, Schwarz T. 2003. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J Immunol 171:3801–3807. [PubMed][CrossRef]
251. Ritter M, Gross O, Kays S, Ruland J, Nimmerjahn F, Saijo S, Tschopp J, Layland LE, Prazeres da Costa C. 2010. Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proc Natl Acad Sci U S A 107:20459–20464. [PubMed][CrossRef]
252. Barrett NA, Maekawa A, Rahman OM, Austen KF, Kanaoka Y. 2009. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J Immunol 182:1119–1128. [PubMed][CrossRef]
253. Suram S, Gangelhoff TA, Taylor PR, Rosas M, Brown GD, Bonventre JV, Akira S, Uematsu S, Williams DL, Murphy RC, Leslie CC. 2010. Pathways regulating cytosolic phospholipase A 2 activation and eicosanoid production in macrophages by Candida albicans. J Biol Chem 285:30676–30685. [PubMed][CrossRef]
254. McDonald JU, Rosas M, Brown GD, Jones SA, Taylor PR. 2012. Differential dependencies of monocytes and neutrophils on dectin-1, dectin-2 and complement for the recognition of fungal particles in inflammation. PLoS One 7:e45781. doi:10.1371/journal.pone.0045781. [PubMed][CrossRef]
255. Zhu LL, Zhao XQ, Jiang C, You Y, Chen XP, Jiang YY, Jia XM, Lin X. 2013. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 39:324–334. [PubMed][CrossRef]
256. Kerscher B, Wilson GJ, Reid DM, Mori D, Taylor JA, Besra GS, Yamasaki S, Willment JA, Brown GD. 2015. The mycobacterial receptor, Clec4d (CLECSF8, MCL) is co-regulated with Mincle and upregulated on mouse myeloid cells following microbial challenge. Eur J Immunol 46:381–389. [PubMed][CrossRef]
257. Barrett NA, Rahman OM, Fernandez JM, Parsons MW, Xing W, Austen KF, Kanaoka Y. 2011. Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes. J Exp Med 208:593–604. [PubMed][CrossRef]
258. Parsons MW, Li L, Wallace AM, Lee MJ, Katz HR, Fernandez JM, Saijo S, Iwakura Y, Austen KF, Kanaoka Y, Barrett NA. 2014. Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization. J Immunol 192:1361–1371. [PubMed][CrossRef]
259. Norimoto A, Hirose K, Iwata A, Tamachi T, Yokota M, Takahashi K, Saijo S, Iwakura Y, Nakajima H. 2014. Dectin-2 promotes house dust mite-induced Th2 and Th17 cell differentiation and allergic airway inflammation in mice. Am J Respir Cell Mol Biol 51:201–209. [PubMed][CrossRef]
260. Clarke DL, Davis NH, Campion CL, Foster ML, Heasman SC, Lewis AR, Anderson IK, Corkill DJ, Sleeman MA, May RD, Robinson MJ. 2014. Dectin-2 sensing of house dust mite is critical for the initiation of airway inflammation. Mucosal Immunol 7:558–567. [PubMed][CrossRef]
261. Hu XP, Wang RY, Wang X, Cao YH, Chen YQ, Zhao HZ, Wu JQ, Weng XH, Gao XH, Sun RH, Zhu LP. 2015. Dectin-2 polymorphism associated with pulmonary cryptococcosis in HIV-uninfected Chinese patients. Med Mycol 53:810–816. [PubMed][CrossRef]
262. Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. 2008. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol 9:1179–1188. [PubMed][CrossRef]
263. Lobato-Pascual A, Saether PC, Fossum S, Dissen E, Daws MR. 2013. Mincle, the receptor for mycobacterial cord factor, forms a functional receptor complex with MCL and FcεRI-γ. Eur J Immunol 43:3167–3174. [PubMed][CrossRef]
264. Miyake Y, Toyonaga K, Mori D, Kakuta S, Hoshino Y, Oyamada A, Yamada H, Ono K, Suyama M, Iwakura Y, Yoshikai Y, Yamasaki S. 2013. C-type lectin MCL is an FcRγ-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor. Immunity 38:1050–1062. [PubMed][CrossRef]
265. Miyake Y, Masatsugu OH, Yamasaki S. 2015. C-type lectin receptor MCL facilitates Mincle expression and signaling through complex formation. J Immunol 194:5366–5374. [PubMed][CrossRef]
266. Zhao XQ, Zhu LL, Chang Q, Jiang C, You Y, Luo T, Jia XM, Lin X. 2014. C-type lectin receptor Dectin-3 mediates trehalose 6,6′-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation. J Biol Chem 289:30052–30062. [PubMed][CrossRef]
267. Graham LM, Gupta V, Schafer G, Reid DM, Kimberg M, Dennehy KM, Hornsell WG, Guler R, Campanero-Rhodes MA, Palma AS, Feizi T, Kim SK, Sobieszczuk P, Willment JA, Brown GD. 2012. The C-type lectin receptor CLECSF8 (CLEC4D) is expressed by myeloid cells and triggers cellular activation through Syk kinase. J Biol Chem 287:25964–25974. [PubMed][CrossRef]
268. Flornes LM, Bryceson YT, Spurkland A, Lorentzen JC, Dissen E, Fossum S. 2004. Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics 56:506–517. [PubMed][CrossRef]
269. Vijayan D, Radford KJ, Beckhouse AG, Ashman RB, Wells CA. 2012. Mincle polarizes human monocyte and neutrophil responses to Candida albicans. Immunol Cell Biol 90:889–895. [PubMed][CrossRef]
270. Kawata K, Illarionov P, Yang GX, Kenny TP, Zhang W, Tsuda M, Ando Y, Leung PS, Ansari AA, Eric Gershwin M. 2012. Mincle and human B cell function. J Autoimmun 39:315–322. [PubMed][CrossRef]
271. Lee WB, Kang JS, Yan JJ, Lee MS, Jeon BY, Cho SN, Kim YJ. 2012. Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the Mincle pathway. PLoS Pathog 8:e1002614. doi:10.1371/journal.ppat.1002614. [PubMed][CrossRef]
272. Schweneker K, Gorka O, Schweneker M, Poeck H, Tschopp J, Peschel C, Ruland J, Gross O. 2012. The mycobacterial cord factor adjuvant analogue trehalose-6,6′-dibehenate (TDB) activates the Nlrp3 inflammasome. Immunobiology 218:664–673. [PubMed][CrossRef]
273. Balch SG, McKnight AJ, Seldin MF, Gordon S. 1998. Cloning of a novel C-type lectin expressed by murine macrophages. J Biol Chem 273:18656–18664. [PubMed][CrossRef]
274. Schoenen H, Huber A, Sonda N, Zimmermann S, Jantsch J, Lepenies B, Bronte V, Lang R. 2014. Differential control of Mincle-dependent cord factor recognition and macrophage responses by the transcription factors C/EBPβ and HIF1α. J Immunol 193:3664–3675. [PubMed][CrossRef]
275. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Akira S. 1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J Immunol 163:5039–5048. [PubMed]
276. Arce I, Martínez-Muñoz L, Roda-Navarro P, Fernández-Ruiz E. 2004. The human C-type lectin CLECSF8 is a novel monocyte/macrophage endocytic receptor. Eur J Immunol 34:210–220. [PubMed][CrossRef]
277. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. 2009. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206:2879–2888. [PubMed][CrossRef]
278. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, Brown GD, Wells C, Lang R. 2010. Cutting edge: mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184:2756–2760. [PubMed][CrossRef]
279. Sharma A, Steichen AL, Jondle CN, Mishra BB, Sharma J. 2014. Protective role of Mincle in bacterial pneumonia by regulation of neutrophil mediated phagocytosis and extracellular trap formation. J Infect Dis 209:1837–1846. [PubMed][CrossRef]
280. Yamasaki S, Matsumoto M, Takeuchi O, Matsuzawa T, Ishikawa E, Sakuma M, Tateno H, Uno J, Hirabayashi J, Mikami Y, Takeda K, Akira S, Saito T. 2009. C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proc Natl Acad Sci U S A 106:1897–1902. [PubMed][CrossRef]
281. Lee RT, Hsu TL, Huang SK, Hsieh SL, Wong CH, Lee YC. 2011. Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities. Glycobiology 21:512–520. [PubMed][CrossRef]
282. Furukawa A, Kamishikiryo J, Mori D, Toyonaga K, Okabe Y, Toji A, Kanda R, Miyake Y, Ose T, Yamasaki S, Maenaka K. 2013. Structural analysis for glycolipid recognition by the C-type lectins Mincle and MCL. Proc Natl Acad Sci U S A 110:17438–17443. [PubMed][CrossRef]
283. Feinberg H, Jégouzo SA, Rowntree TJ, Guan Y, Brash MA, Taylor ME, Weis WI, Drickamer K. 2013. Mechanism for recognition of an unusual mycobacterial glycolipid by the macrophage receptor mincle. J Biol Chem 288:28457–28465. [PubMed][CrossRef]
284. Hattori Y, Morita D, Fujiwara N, Mori D, Nakamura T, Harashima H, Yamasaki S, Sugita M. 2014. Glycerol monomycolate is a novel ligand for the human, but not mouse macrophage inducible C-type lectin, Mincle. J Biol Chem 289:15405–15412. [PubMed][CrossRef]
285. Werninghaus K, Babiak A, Gross O, Hölscher C, Dietrich H, Agger EM, Mages J, Mocsai A, Schoenen H, Finger K, Nimmerjahn F, Brown GD, Kirschning C, Heit A, Andersen P, Wagner H, Ruland J, Lang R. 2009. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation. J Exp Med 206:89–97. [PubMed][CrossRef]
286. Shenderov K, Barber DL, Mayer-Barber KD, Gurcha SS, Jankovic D, Feng CG, Oland S, Hieny S, Caspar P, Yamasaki S, Lin X, Ting JP, Trinchieri G, Besra GS, Cerundolo V, Sher A. 2013. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome. J Immunol 190:5722–5730. [PubMed][CrossRef]
287. Heitmann L, Schoenen H, Ehlers S, Lang R, Hölscher C. 2013. Mincle is not essential for controlling Mycobacterium tuberculosis infection. Immunobiology 218:506–516. [PubMed][CrossRef]
288. Behler F, Steinwede K, Balboa L, Ueberberg B, Maus R, Kirchhof G, Yamasaki S, Welte T, Maus UA. 2012. Role of Mincle in alveolar macrophage-dependent innate immunity against mycobacterial infections in mice. J Immunol 189:3121–3129. [PubMed][CrossRef]
289. Wilson GJ, Marakalala MJ, Hoving JC, van Laarhoven A, Drummond RA, Kerscher B, Keeton R, van de Vosse E, Ottenhoff TH, Plantinga TS, Alisjahbana B, Govender D, Besra GS, Netea MG, Reid DM, Willment JA, Jacobs M, Yamasaki S, van Crevel R, Brown GD. 2015. The C-type lectin receptor CLECSF8/CLEC4D is a key component of anti-mycobacterial immunity. Cell Host Microbe 17:252–259. [PubMed][CrossRef]
290. Steichen AL, Binstock BJ, Mishra BB, Sharma J. 2013. C-type lectin receptor Clec4d plays a protective role in resolution of Gram-negative pneumonia. J Leukoc Biol 94:393–398. [PubMed][CrossRef]
291. Wells CA, Salvage-Jones JA, Li X, Hitchens K, Butcher S, Murray RZ, Beckhouse AG, Lo YL, Manzanero S, Cobbold C, Schroder K, Ma B, Orr S, Stewart L, Lebus D, Sobieszczuk P, Hume DA, Stow J, Blanchard H, Ashman RB. 2008. The macrophage-inducible C-type lectin, Mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 180:7404–7413. [PubMed][CrossRef]
292. Sousa MG, Reid DM, Schweighoffer E, Tybulewicz V, Ruland J, Langhorne J, Yamasaki S, Taylor PR, Almeida SR, Brown GD. 2011. Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 9:436–443. [PubMed][CrossRef]
293. Kiyotake R, Oh-Hora M, Ishikawa E, Miyamoto T, Ishibashi T, Yamasaki S. 2015. Human Mincle binds to cholesterol crystals and triggers innate immune responses. J Biol Chem 290:25322–25332. [PubMed][CrossRef]
294. Tanaka M, Ikeda K, Suganami T, Komiya C, Ochi K, Shirakawa I, Hamaguchi M, Nishimura S, Manabe I, Matsuda T, Kimura K, Inoue H, Inagaki Y, Aoe S, Yamasaki S, Ogawa Y. 2014. Macrophage-inducible C-type lectin underlies obesity-induced adipose tissue fibrosis. Nat Commun 5:4982. doi:10.1038/ncomms5982. [CrossRef]
295. Wu XY, Guo JP, Yin FR, Lu XL, Li R, He J, Liu X, Li ZG. 2012. Macrophage-inducible C-type lectin is associated with anti-cyclic citrullinated peptide antibodies-positive rheumatoid arthritis in men. Chin Med J (Engl) 125:3115–3119. [PubMed]
296. Suzuki Y, Nakano Y, Mishiro K, Takagi T, Tsuruma K, Nakamura M, Yoshimura S, Shimazawa M, Hara H. 2013. Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke. Sci Rep 3:3177. doi:10.1038/srep03177. [PubMed][CrossRef]
297. Ichioka M, Suganami T, Tsuda N, Shirakawa I, Hirata Y, Satoh-Asahara N, Shimoda Y, Tanaka M, Kim-Saijo M, Miyamoto Y, Kamei Y, Sata M, Ogawa Y. 2011. Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans. Diabetes 60:819–826. [PubMed][CrossRef]
298. He Y, Xu L, Li B, Guo ZN, Hu Q, Guo Z, Tang J, Chen Y, Zhang Y, Tang J, Zhang JH. 2015. Macrophage-inducible C-type lectin/spleen tyrosine kinase signaling pathway contributes to neuroinflammation after subarachnoid hemorrhage in rats. Stroke 46:2277–2286. [PubMed][CrossRef]
299. Taylor ME, Conary JT, Lennartz MR, Stahl PD, Drickamer K. 1990. Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains. J Biol Chem 265:12156–12162. [PubMed]
300. Martinez-Pomares L. 2012. The mannose receptor. J Leukoc Biol 92:1177–1186. [PubMed][CrossRef]
301. Boskovic J, Arnold JN, Stilion R, Gordon S, Sim RB, Rivera-Calzada A, Wienke D, Isacke CM, Martinez-Pomares L, Llorca O. 2006. Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor. J Biol Chem 281:8780–8787. [PubMed][CrossRef]
302. McKenzie EJ, Taylor PR, Stillion RJ, Lucas AD, Harris J, Gordon S, Martinez-Pomares L. 2007. Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol 178:4975–4983. [PubMed][CrossRef]
303. Stein M, Keshav S, Harris N, Gordon S. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176:287–292. [PubMed][CrossRef]
304. Gordon S. 2003. Alternative macrophage activation. Nat Rev Immunol 3:23–35. [PubMed][CrossRef]
305. Heinsbroek SE, Squadrito ML, Schilderink R, Hilbers FW, Verseijden C, Hofmann M, Helmke A, Boon L, Wildenberg ME, Roelofs JJ, Ponsioen CY, Peters CP, Te Velde AA, Gordon S, De Palma M, de Jonge WJ. 2015. miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation. Mucosal Immunol 9:960–973. [PubMed][CrossRef]
306. Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, De Palma M. 2012. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 1:141–154. [PubMed][CrossRef]
307. Martínez-Pomares L, Mahoney JA, Káposzta R, Linehan SA, Stahl PD, Gordon S. 1998. A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. J Biol Chem 273:23376–23380. [PubMed][CrossRef]
308. Moseman AP, Moseman EA, Schworer S, Smirnova I, Volkova T, von Andrian U, Poltorak A. 2013. Mannose receptor 1 mediates cellular uptake and endosomal delivery of CpG-motif containing oligodeoxynucleotides. J Immunol 191:5615–5624. [PubMed][CrossRef]
309. Royer PJ, Emara M, Yang C, Al-Ghouleh A, Tighe P, Jones N, Sewell HF, Shakib F, Martinez-Pomares L, Ghaemmaghami AM. 2010. The mannose receptor mediates the uptake of diverse native allergens by dendritic cells and determines allergen-induced T cell polarization through modulation of IDO activity. J Immunol 185:1522–1531. [PubMed][CrossRef]
310. Everts B, Hussaarts L, Driessen NN, Meevissen MH, Schramm G, van der Ham AJ, van der Hoeven B, Scholzen T, Burgdorf S, Mohrs M, Pearce EJ, Hokke CH, Haas H, Smits HH, Yazdanbakhsh M. 2012. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med 209:1753–1767. [PubMed][CrossRef]
311. Zehner M, Chasan AI, Schuette V, Embgenbroich M, Quast T, Kolanus W, Burgdorf S. 2011. Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc Natl Acad Sci U S A 108:9933–9938. [PubMed][CrossRef]
312. Ezekowitz RA, Sastry K, Bailly P, Warner A. 1990. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med 172:1785–1794. [PubMed][CrossRef]
313. Le Cabec V, Emorine LJ, Toesca I, Cougoule C, Maridonneau-Parini I. 2005. The human macrophage mannose receptor is not a professional phagocytic receptor. J Leukoc Biol 77:934–943. [PubMed][CrossRef]
314. Galès A, Conduché A, Bernad J, Lefevre L, Olagnier D, Béraud M, Martin-Blondel G, Linas MD, Auwerx J, Coste A, Pipy B. 2010. PPARγ controls Dectin-1 expression required for host antifungal defense against Candida albicans. PLoS Pathog 6:e1000714. doi:10.1371/journal.ppat.1000714.
315. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, van den Berg WB, Williams DL, van der Meer JW, Joosten LA, Netea MG. 2009. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5:329–340. [PubMed][CrossRef]
316. Loures FV, Araújo EF, Feriotti C, Bazan SB, Calich VL. 2015. TLR-4 cooperates with Dectin-1 and mannose receptor to expand Th17 and Tc17 cells induced by Paracoccidioides brasiliensis stimulated dendritic cells. Front Microbiol 6:261. doi:10.3389/fmicb.2015.00261. [CrossRef]
317. Chieppa M, Bianchi G, Doni A, Del Prete A, Sironi M, Laskarin G, Monti P, Piemonti L, Biondi A, Mantovani A, Introna M, Allavena P. 2003. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 171:4552–4560. [PubMed][CrossRef]
318. Lee SJ, Zheng NY, Clavijo M, Nussenzweig MC. 2003. Normal host defense during systemic candidiasis in mannose receptor-deficient mice. Infect Immun 71:437–445. [PubMed][CrossRef]
319. Swain SD, Lee SJ, Nussenzweig MC, Harmsen AG. 2003. Absence of the macrophage mannose receptor in mice does not increase susceptibility to Pneumocystis carinii infection in vivo. Infect Immun 71:6213–6221. [PubMed][CrossRef]
320. Court N, Vasseur V, Vacher R, Frémond C, Shebzukhov Y, Yeremeev VV, Maillet I, Nedospasov SA, Gordon S, Fallon PG, Suzuki H, Ryffel B, Quesniaux VF. 2010. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J Immunol 184:7057–7070. [PubMed][CrossRef]
321. Dan JM, Kelly RM, Lee CK, Levitz SM. 2008. Role of the mannose receptor in a murine model of Cryptococcus neoformans infection. Infect Immun 76:2362–2367. [PubMed][CrossRef]
322. Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, Lee YC, Feizi T, Langen H, Nussenzweig MC. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898–1901. [PubMed][CrossRef]
323. Emara M, Royer PJ, Abbas Z, Sewell HF, Mohamed GG, Singh S, Peel S, Fox J, Shakib F, Martinez-Pomares L, Ghaemmaghami AM. 2011. Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity. J Biol Chem 286:13033–13040. [PubMed][CrossRef]
324. Chavele KM, Martinez-Pomares L, Domin J, Pemberton S, Haslam SM, Dell A, Cook HT, Pusey CD, Gordon S, Salama AD. 2010. Mannose receptor interacts with Fc receptors and is critical for the development of crescentic glomerulonephritis in mice. J Clin Invest 120:1469–1478. [PubMed][CrossRef]
325. Hattori T, Konno S, Hizawa N, Isada A, Takahashi A, Shimizu K, Shimizu K, Gao P, Beaty TH, Barnes KC, Huang SK, Nishimura M. 2009. Genetic variants in the mannose receptor gene ( MRC1) are associated with asthma in two independent populations. Immunogenetics 61:731–738. [PubMed][CrossRef]
326. Hattori T, Konno S, Takahashi A, Isada A, Shimizu K, Shimizu K, Taniguchi N, Gao P, Yamaguchi E, Hizawa N, Huang SK, Nishimura M. 2010. Genetic variants in mannose receptor gene ( MRC1) confer susceptibility to increased risk of sarcoidosis. BMC Med Genet 11:151. doi:10.1186/1471-2350-11-151. [CrossRef]
327. Zhang X, Li X, Zhang W, Wei L, Jiang T, Chen Z, Meng C, Liu J, Wu F, Wang C, Li F, Sun X, Li Z, Li JC. 2013. The novel human MRC1 gene polymorphisms are associated with susceptibility to pulmonary tuberculosis in Chinese Uygur and Kazak populations. Mol Biol Rep 40:5073–5083. [PubMed][CrossRef]
328. Park CG. 2014. Vaccine strategies utilizing C-type lectin receptors on dendritic cells in vivo. Clin Exp Vaccine Res 3:149–154. [PubMed][CrossRef]
329. Dambuza IM, Brown GD. 2015. C-type lectins in immunity: recent developments. Curr Opin Immunol 32:21–27. [PubMed][CrossRef]

Article metrics loading...



Lectins recognize a diverse array of carbohydrate structures and perform numerous essential biological functions. Here we focus on only two families of lectins, the Siglecs and C-type lectins. Triggering of intracellular signaling cascades following ligand recognition by these receptors can have profound effects on the induction and modulation of immunity. In this chapter, we provide a brief overview of each family and then focus on selected examples that highlight how these lectins can influence myeloid cell functioning in health and disease. Receptors that are discussed include Sn (Siglec-1), CD33 (Siglec-3), and Siglec-5, -7, -8, -9, -10, -11, -14, -15, -E, -F, and -G as well as Dectin-1, MICL, Dectin-2, Mincle/MCL, and the macrophage mannose receptor.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...



Image of FIGURE 1

Click to view


Siglecs in humans and mice. There are two subgroups of Siglecs: One group contains Siglecs that are conserved in all mammalian species and the other group contains CD33-related Siglecs that appear to be undergoing rapid evolution in primates. The cell types expressing highest levels of each Siglec are indicated. B, B cell; Eos, eosinophil; Mac, macrophage; mDC, myeloid dendritic cell; Mon, monocyte; Neu, neutrophil; NK, NK cell; Oli, oligodendrocyte; Ost, osteoclast; pDC, plasmacytoid dendritic cell; Pla, placental syncytiotrophoblast; Sch, Schwann cell.

Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

Click to view


Selected signal transduction cascades induced by C-type lectin receptors. Activation receptors, such as Dectin-1, Dectin-2, Mincle, and MCL, induce cellular responses primarily through Syk kinase, although other pathways can be involved, such as those induced by Raf-1. Inhibitory receptors, such as MICL, activate protein tyrosine phosphatases (PTPs, such as SHP-1), which attenuate activation pathways. DNGR-1 (CLEC9A), not discussed in the text, is an actin-binding receptor expressed by CD8 DCs and involved in antigen cross-presentation. Reprinted from reference 329 , with permission.

Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

Click to view


Dectin-1 can mediate the nonopsonic phagocytosis of fluorescently labeled fungal particles (green) via actin (red)-based phagocytic cups. Reprinted from reference 155 , with permission.

Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4

Click to view


The macrophage mannose receptor. Structure of the MR indicating its exogenous and endogenous ligands (including those in tissues). Mɸ, macrophage; LDL, low-density lipoprotein; HBV, hepatitis B virus; CPS, capsular polysaccharide; SEA, secreted egg antigen; Adam-13, a disintegrin and metalloprotease 13. Reprinted from reference 300 , with permission.

Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016
Permissions and Reprints Request Permissions
Download as Powerpoint


Generic image for table

Click to view


Lectin families

Source: microbiolspec September 2016 vol. 4 no. 5 doi:10.1128/microbiolspec.MCHD-0036-2016

Supplemental Material

No supplementary material available for this content.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error